پديد آورندگان :
Jalilian Ali نويسنده , Javadi Ebrahim نويسنده , Akrami Mohamad نويسنده , Fakhrzadeh Hossin نويسنده , Heshmat Ramin نويسنده , Rahmani Mazaher نويسنده , Bandarianv Fatemeh نويسنده
چكيده لاتين :
Background: Recently another member of the paraoxonase gene family designated
paraoxonase-2 has been identified. Paraoxonase-2 has antioxidant properties similar to
paraoxonase-1 and paraoxonase-3. However, in contrast to paraoxonase-1 and paraoxonase-3,
paraoxonase-2 is not associated with high-density lipoprotein and may only exert its antioxidant
function at the cellular level.
Methods: We assessed the frequency and genotype distribution of cys 311 ser paraoxonase-2
polymorphism in 300 subjects (>40 years old) with angiographic documentation of coronary artery
disease (150 patients with >50% stenosis served as cases and 150 individuals with <20% stenosis
served as controls) to determine the possible association between this mutation and susceptibility
for coronary artery disease. The paraoxonase-2 genotypes were determined by polymerase chain
reaction and DdeI restriction enzyme digestion.
Results: The cases (coronary artery disease positive patients) showed significant differences
in the distribution of cys 311 ser paraoxonase-2 genotypes as compared with the controls
(coronary artery disease negative subjects, P=0.015). The analysis of paraoxonase-2 genotypes
distribution showed higher percentage of CC genotype among coronary artery disease positive
compared with coronary artery disease negative (P=0.008). After controlling for other risk factors,
the cys 311 ser polymorphism had not correlation with age, body mass index, gender, smoking,
diabetes, level of high-density lipoprotein, low-density lipoprotein, triglyceride, and total
cholesterol.
Conclusion: Our data indicate a major effect of the paraoxonase-2 polymorphism on coronary
artery disease risk in patients referred to Shariati Hospital in Tehran.